Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte colony-stimulating factor and leukemogenesis.

Lorena Lobo de Figueiredo1, Rodrigo Siqueira de Abreu e Lima, Eduardo Magalhães Rego

  • 1Division of Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, Campus USP, 14049-900, Ribeirão Preto, São Paulo, Brazil.

Mediators of Inflammation
|June 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Haematologica·2026
Same author

Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.

European journal of pharmacology·2026
Same author

Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia.

Hematology, transfusion and cell therapy·2026
Same author

Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches.

Blood research·2025
Same author

Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

The tower of babel in hematology: The World Health Organization and International Consensus Classification systems.

Hematology, transfusion and cell therapy·2025
Same journal

Correction to "Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism".

Mediators of inflammation·2026
Same journal

Propofol and Salvianolic Acid a Synergistically Attenuate LPS-Induced Myocardial Pyroptosis in Diabetic Mice via the SIRT1/HMGB1 Pathway.

Mediators of inflammation·2026
Same journal

Association of C-Reactive Protein-Triglyceride Glucose Index With Chronic Obstructive Pulmonary Disease: Results From the NHANES and CHARLS Cohorts.

Mediators of inflammation·2026
Same journal

Moxibustion Modulates ALOX15-Mediated Lipid Peroxidation to Inhibit Ferroptosis in Synovial Inflammatory Injury of Rheumatoid Arthritis.

Mediators of inflammation·2026
Same journal

Development and Validation of a Cytokine-Based Predictive Model for Acute GvHD and Composite Outcomes in ATG-Based Haploidentical Hematopoietic Stem Cell Transplantation.

Mediators of inflammation·2026
Same journal

Effects of Livergol and Hydroalcoholic Extracts of Barberry, Jujube, and Flixweed on Oxidative Stress and Inflammatory Gene Expression in a MASLD Animal Model.

Mediators of inflammation·2026
See all related articles

Granulocyte colony-stimulating factor (G-CSF) signaling is implicated in leukemia development. Aberrant G-CSF receptor (G-CSF-R) expression and signaling contribute to acute myelogenous leukemia (AML) pathogenesis and influence treatment responses.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Granulocyte colony-stimulating factor (G-CSF) is crucial for granulopoiesis, acting via the G-CSF receptor (G-CSF-R).
  • G-CSF-R signaling involves distinct cytoplasmic regions mediating proliferation, survival, and maturation.
  • Mutations and aberrant signaling pathways can disrupt normal G-CSF-R function.

Purpose of the Study:

  • To investigate the role of G-CSF signaling in leukemogenesis.
  • To explore the involvement of G-CSF-R in acute myelogenous leukemia (AML).
  • To assess G-CSF's impact on specific leukemia subtypes and treatments.

Main Methods:

  • Analysis of G-CSF-R mutations in patients with severe congenital neutropenia and AML.
  • Investigation of AML1-ETO fusion protein effects on G-CSF-R expression.

Related Experiment Videos

  • In vitro and in vivo studies on G-CSF's role in acute promyelocytic leukemia (APL) treatment.

    • Main Results:

    • Truncated G-CSF-R mutations are linked to AML development in neutropenia patients.
    • AML1-ETO disrupts transcription factors, leading to high G-CSF-R levels and proliferation in AML with t(8;21).
    • G-CSF enhances APL cell response to all-trans-retinoic acid and suppresses leukemia in a PLZF-RARalpha model.

    Conclusions:

    • The G-CSF signaling pathway is implicated in the pathogenesis of various leukemias.
    • Aberrant G-CSF-R signaling contributes to AML development and progression.
    • G-CSF may serve as a therapeutic target or co-stimulus in leukemia treatment.